Medtronic CEO Discusses Impact of Tariffs on Fiscal 2027 Earnings
Geoffrey Martha, CEO of Medtronic (MDT), disclosed that tariffs are expected to impact the company's fiscal 2027 earnings by $250 million. This is a reduction from an earlier estimate due to supply chain adjustments and includes $75 million in Q1. The CEO highlighted ongoing pressure from rising input costs, but noted growth areas such as cardiac ablation and acquisitions are helping buffer these impacts.
Tickers: $MDT
Topics: CEO commentary medical technology supply chain adjustments tariffs